Genizon Bioscience licenses Crohn's disease genemap to Genentech
Advertisement
Genizon BioSciences announced a license and collaboration agreement with Genentech, Inc. Genizon grants Genentech an exclusive license to Genizon's GeneMap of disease-associated genes generated from a whole genome association study of Crohn's disease patients from the Quebec Founder Population.
Under the terms of the agreement, Genizon will receive an upfront payment, research funding and milestone payments for each therapeutic product that may emerge from the collaboration. Financial terms were not disclosed.